The clinical use of albumin: The point of view of a specialist in intensive care

Blood Transfusion

Volumn 7, Issue 4, 2009, Pages 259-267

  Caironi, Pietro ^a   Gattinoni, Luciano ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

CLINICAL TRIAL; CRITICALLY ILL PATIENT; DRUG USE; HUMAN; INTENSIVE CARE; MEDICAL SPECIALIST; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PROTEIN METABOLISM; REVIEW; SEPSIS; TREATMENT INDICATION;

HUMANS; INTENSIVE CARE; SERUM ALBUMIN;

EID: 73449085534     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2009.0002-09     Document Type: Review

References (46)

1. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56.
2. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998;317:235-40.
3. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001;135:149-64.
4. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003;237:319-34.
5. Peters T. Historical perspective. All about albumin. San Diego, California: Academic Press Limited; 1996:1-8.
6. Weil MH, Henning RJ, Puri VK. Colloid oncotic pressure: clinical significance. Crit Care Med 1979;7:113-6.
7. Schomerus H, Mayer G. Synthesis rates of albumin and fibrinogen in patients with protein-losing enteropathy and in a patient recovering from protein malnutrition. Digestion 1975;13:201-8.
8. Hafkenscheid JC, Yap SH, van Tongeren JH. Measurement of the rate of synthesis of albumin with 14C-carbonate: a simplified method. Z Klin Chem Klin Biochem 1973;11:147-51.
9. Gersovitz M, Munro HN, Udall J, Young VR. Albumin synthesis in young and elderly subjects using a new stable isotope methodology: response to level of protein intake. Metabolism 1980;29:1075-86.
10. Ballmer PE, McNurlan MA, Milne E, et al. Measurement of albumin synthesis in humans: a new approach employing stable isotopes. Am J Physiol 1990;259:E797-803.
11. Peters T. Metabolism: albumin in the body. All about albumin. San Diego, California: Academic Press Limited; 1996:188-250.
12. Beeken WL, Volwiler W, Goldsworthy PD, et al. Studies of I-131-albumin catabolism and distribution in normal young male adults. J Clin Invest 1962;41:1312-33.
13. Ganong W. Dynamics of blood and lymph flow. Review of medical physiology. Collecticut: Appleton and Lange; 1995:525-41.
14. Peters T Jr. Biosynthesis of rat serum albumin. VII. Effects observed in liver slices. Am J Physiol 1973;224:1363-8.
15. Schnitzer JE, Oh P. Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins. J Biol Chem 1994;269:6072-82.
16. Pardridge WM, Eisenberg J, Cefalu WT. Absence of albumin receptor on brain capillaries in vivo or in vitro. Am J Physiol 1985;249:E264-7.
17. Gattinoni L, Carlesso E, Caironi P. [Albumin administration: volume replacement or pharmacological treatment?]. Minerva Anestesiol 2005;71:27-40.
18. Rothschild MA, Oratz M, Mongelli J, Schreiber SS. Effect of albumin concentration on albumin synthesis in the perfused liver. Am J Physiol 1969;216:1127-30.
19. Dich J, Hansen SE, Thieden HI. Effect of albumin concentration and colloid osmotic pressure on albumin synthesis in the perfused rat liver. Acta Physiol Scand 1973;89:352-8.
20. Schmid M, Schindler R, Weigand K. Is albumin synthesis regulated by the colloid osmotic pressure? Effect of albumin and dextran on albumin and total protein synthesis in isolated rat hepatocytes. Klin Wochenschr 1986;64:23-8.
21. Pietrangelo A, Panduro A, Chowdhury JR, Shafritz DA. Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. J Clin Invest 1992;89:1755-60.
22. Cairo G, Schiaffonati L, Aletti MG, Bernelli-Zazzera A. Effect of post-ischaemic recovery on albumin synthesis and relative amount of translatable albumin messenger RNA in rat liver. Biochem J 1982; 204:197-202.
23. Liao WS, Jefferson LS, Taylor JM. Changes in plasma albumin concentration, synthesis rate, and mRNA level during acute inflammation. Am J Physiol 1986;251:C928-34.
24. Milland J, Tsykin A, Thomas T, et al. Gene expression in regenerating and acute-phase rat liver. Am J Physiol 1990;259:G340-7.
25. Ozaki I, Motomura M, Setoguchi Y, et al. Albumin mRNA expression in human liver diseases and its correlation to serum albumin concentration. Gastroenterol Jpn 1991;26:472-6.
26. Ramadori G, Van Damme J, Rieder H, Meyer zum Buschenfelde KH. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol 1988;18:1259-64.
27. Castell JV, Gomez-Lechon MJ, David M, et al. Acutephase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179-86.
28. Brenner DA, Buck M, Feitelberg SP, Chojkier M. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest 1990;85:248-55.
29. King TP. On the sulfhydryl group of human plasma albumin. J Biol Chem 1961;236:C5.
30. Quinlan GJ, Margarson MP, Mumby S, et al. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998;95:459-65.
31. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an Snitroso adduct of serum albumin. Proc. Natl Acad Sci USA 1992;89:7674-7.
32. Sudlow G, Birkett DJ, Wade DN. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 1975;11:824-32.
33. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000; 85:599-610.
34. Reeves RB. Temperature-induced changes in blood acidbase status: Donnan rCl and red cell volume. J Appl Physiol 1976;40:762-7.
35. Hori N, Wiest R, Groszmann RJ. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats. Hepatology 1998;28:1467-73.
36. Powers KA, Kapus A, Khadaroo RG, et al. Twenty-five percent albumin prevents lung injury following shock/ resuscitation. Crit Care Med 2003;31:2355-63.
37. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997;50:693-703.
38. Roberts I, Bunn F. Egg on their faces. The story of human albumin solution. Eval Health Prof 2002; 25:130-8.
39. Dubois MJ, Orellana-Jimenez C, Melot C, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006;34:2536-40.
40. Liumbruno GM, Bennardello F, Lattanzio A. et al. Recommendations for the use of albumin and immunoglobulins. Blood Transfus 2009; 7: 216-34
41. Vincent JL, de MA, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-800.
42. Myburgh J, Cooper J, Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007;357:874-84.
43. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001;29:1261-7.
44. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
45. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
46. Rivers E, Nguyen B, Havstad S, et al. Early goaldirected therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368- 77.